News
AstraZeneca pledges $3.5bn to biopharma research and manufacturing The company is using a multi-pronged approach to strengthen its business in multiple modalities.
Less errors. Sustainable scaleup. Read about the real results this large biopharma achieved in their aliquoting process using Linkit®️ AX.
Ingress of carbon dioxide into bulk drug substance (BDS) containers that are stored and shipped on dry ice is a serious and often understated problem. Bottles are a container of choice for freezing ...
Learn about a new purification approach starting from E. coli through to mRNA production, resulting in improved recoveries, extra-low protein impurities, and very efficient dsRNA removal.
Jing Guo, Research Scientist, MITThis interview features: Jing Guo, Research Scientist, MIT, from BioProcess International 2023.
Learn about the numerous benefits of using a high-quality GMP-grade plasmid platform when manufacturing your pharmaceuticals.
This interview features: Lee Willmon, HSE Operations, Novartis, from BPI West 2024.
This webinar will discuss the process of assay development, qualification, and validation for critical potency assays and how Sartorius supports customers through this vital step.
Explore the latest news and expert commentary by Inês do Carmo Gonçalves, brought to you by the Contributor of BioProcess International.
You want to scale and deliver your vaccine to the world quickly. Our collaborative global vaccine capabilities will take your innovation from pre-clinical to full-scale GMP-manufacturing efficiently, ...
Working with the right partner for cell & gene therapies can help ease the increasingly common problems with scale, access to high-demand raw material, viral vector production, and quality ...
Vaccines have been protecting against disease since the late 1700s. They function by triggering the immune system to generate short-term and long-term responses. Because there are many pathogens, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results